Status and phase
Conditions
Treatments
About
Prospective, randomised, controlled trial of a novel implant intended for use during surgical repair of lacerated Zone 2 flexor digitorum profundus tendons.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Pregnant or planning to become pregnant during the follow-up period
Autoimmune disorder(s)
Type 1 diabetes mellitus or clinical history of poorly controlled Type 2 diabetes mellitus
Lack of proper cutaneous coverage at repair site
Concomitant fracture
Amputated digit(s)
Arthritis of the hand
Prior hand trauma with residual impact to function
Congenital hand defect
Conditions that would affect comparative measurements in the uninjured hand
Tendon laceration caused by a crush injury
Prior sensory impairment in digits of either hand. Note: Participants with nerve injuries associated with the trauma causing the current flexor tendon injury are eligible for enrollment
Vascular injuries that require revascularisation procedures
Ischemia and/or blood supply compromise
Prior or current infections at or near the intended implant site
Active sepsis, MRSA, or other conditions that may prevent healing
History of foreign-body sensitivity to 316 L Stainless Steel or UHMWPE
Implantation of CoNextionsTR Implant would result in physical contact with other metal implants made of material other than implant grade stainless steel such as titanium, titanium alloys, cobalt chromium, or other dissimilar metals
Any condition(s) which, in the opinion of the investigator, may impact the participant's ability to properly follow-up or otherwise be at-risk for following protocol instructions
Currently participating in another clinical/device trial
The following criteria, determined during the surgical procedure, will also cause an individual to be excluded from the study:
Surgical site access less than 20 mm in total or less than 10 mm on either side of intended implant site
Injured tendon is outside of the width range (3.0-7.0 mm) and thickness range (1.5-4.0 mm) specified for the CoNextionsTR Implant System.
Primary purpose
Allocation
Interventional model
Masking
90 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal